• small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Investors Overview

CORPORATE PROFILE

MiMedx® is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. “Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. The MiMedx allograft product families include our: dHACM family with AmnioFix®, EpiFix® and EpiBurn® brands; Amniotic Fluid family with OrthoFlo brand; Umbilical family with EpiCord™ and AmnioCord™ brands; Placental Collagen family with CollaFix™ and AmnioFill™ brands; Bone family with Physio® brand; and Skin family with AlloBurn™ brand. AmnioFix, EpiFix, and EpiBurn are our tissue technologies processed from human amniotic membrane; OrthoFlo is an amniotic fluid derived allograft; EpiCord™ and AmnioCord™ are derived from the umbilical cord; Physio is a unique bone grafting material comprised of 100% bone tissue with no added carrier; AlloBurn is a skin product derived from human skin designed for the treatment of burns; and CollaFix, our next brand we plan to commercialize, is our collagen fiber technology, developed with our patented cross-linking polymers, designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair. We process the human amniotic membrane utilizing our proprietary PURION® Process, to produce a safe and effective implant. MiMedx proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. MiMedx is the leading supplier of amniotic tissue, having supplied over 700,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

MIMEDX GROUP INC(Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$13.51
Change Stock is Up 0.31 (2.35%)
Volume2,754,058

10/16/17  4:00 p.m. ET

Minimum 20 minute delay

Stock chart for: MDXG.O.  Currently trading at $13.51 with a 52 week high of $17.47 and a 52 week low of $7.64.
Data Provided by Thomson Reuters

NEWS AND EVENTS

View All
Oct-16-2017
MiMedx Announces Release Date for 2017 Third Quarter ResultsMARIETTA, Ga., Oct. 16, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utiliz

Read More

Oct-11-2017
Multicenter Randomized Controlled VLU Clinical Study Published in the International Wound Journal Demonstrates Significantly Higher Healing Rates of MiMedx EpiFix®MIMEDX REITERATES ITS EXPECTATION FOR THIS STUDY TO EXPAND THE COMPANY'S VLU INSURANCE COVERAGE BY AN ADDITIONAL $75 MILLION TO $150 MILLION ANNUAL REVENUE OPPORTUNITY MIMEDX EPIFIX SHO

Read More

Oct-10-2017
MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 PercentMiMedx To Host Conference Call on Wednesday, October 11, 2017 at 10:30AM Eastern Time MARIETTA, Ga., Oct. 10, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biophar

Read More

RECEIVE E-MAIL ALERTS

Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever MIMEDX GROUP INC posts new information to the site. Just enter your e-mail address and click Submit.
 

PRODUCTS

Products

CONTACT US

888.543.1917

Products

CONTACT US

888.543.1917